A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients (FISCO)
Status
Completed
Conditions
Sickle Cell Disease
Details and patient eligibility
About
A long term observational study in sickle cell disease will enhance the understanding of the disease patterns, current transfusion practices, treatments and outcomes in sickle cell disease.
Enrollment
498 patients
Sex
All
Ages
2+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- Male or female patients with HbSS, HbS/beta-thalassemia and HbSC
- Age > 2 years old.
- Written informed consent by the patient or legal guardians, and pediatric assent where indicated.
Exclusion criteria
- Patients with Sickle Cell trait (HbAS) are not eligible for the study
- Patient or legal guardians unable or unwilling to give consent, or pediatric assent where indicated.
Trial design
498 participants in 3 patient groups
No treatment
Description:
Patients aged 2 to less than 12
No treatment patients aged 12 to less than 18
Description:
Patients aged 12 to less than 18
No treatment Patients greater than 18 years
Description:
patients greater than 18 years
Trial contacts and locations
42
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems